YCBD (cbdmd.com) Net Profit

Corporate emblem and logo of cbdMD, Inc. (YCBD)

cbdMD, Inc. (YCBD) generates revenue through the sale of CBD products for humans and animals via e-commerce and US retail. The company's financial performance reflects a current balance of demand, with the metric valued at -0.00. Success is based on the legality of sales and consumer trust. The streamlined operation of partner plants and the excellent condition of capacities guarantee stable product output.

YCBD (cbdmd.com) Company Net Income history from 07/04/2022 to 10/31/2026

Financial and market metric breakdowns for cbdmd.com (YCBD)

- price and consensus price forecast:
Stock Quotes cbdMD|YCBD - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization cbdMD, Inc.|YCBD - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share cbdMD|YCBD - Company Book Value|Market-to-Book Ratio cbdmd.com|YCBD - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital cbdMD, Inc.|YCBD - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital cbdMD|YCBD - Company Aggregate Debts|Debts to Book Value cbdMD, Inc.|YCBD - Company Long-Term Debt|Company Short-Term Loans and Borrowings cbdMD|Quick Liquidity Indicator cbdmd.com
- net income and valuation multiples indicators:
YCBD - Net Profit
Fundamental valuation:YCBD cbdMD Corp
Flagship merchandise of cbdMD Inc.

This indicator measures the daily net income delta, allowing for the identification of the issuer's hidden operational resilience during periods of price stagnation. Analyzing the income and expense balance of cbdMD, Inc. (YCBD) is critical due to the moderate cyclicality of demand for CBD products and consumer sensitivity to household budgets, making the monitoring of current profit the primary filter against sudden capital loss.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Net Profit TBPH (Theravance Biopharma, Inc.)|AQST - Net Income|scPharma - Net Profit|TECX: Company Net Income|TNXP: Net Profit|Company Profit SXTC|Company Net Income Eupraxia Pharmaceuticals, Inc.|Net Income BioHarvest Sciences, Inc. (BHST)|Net Profit EXOZ|oramed.com - Company Profit|Entera Bio - Net Income|Final Profit HYFT|ABVC BioPharma, Inc. - Net Profit|Net Financial Result Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited (QNTM) - Company Net Income|Company Profit FGEN|TELO (Telomir Pharmaceuticals) - Net Profit|Net Income Rani Therapeutics Inc (RANI)|Net Income SNYR (Synergy CHC Corp)|Net Financial Result rallybio.com|Lexaria Bioscience Corp. - Net Income|Pulmatrix Corporation (PULM) - Company Net Income|Pheton - Net Profit|Aptorum Group Limited (APM) - Net Income|LYRA: Net Profit|IBO (impactbiomedinc.com) - Company Net Income|TNFA (TNF Pharmaceuticals Inc.) - Net Profit|Company Profit PRFX (PainReform Corp)|Company Net Income Altamira Therapeutics (CYTO)|LIPO: Profit After Tax|Net Profit OPTN (OptiNose)|Final Profit PIRS|Procaps Group SA - Net Profit|PTPI - Net Profit|Qilian International (QLI) - Company Net Income|acelyrin.com - Final Profit|Company Net Income TFF Pharmaceuticals, Inc.